Accendra Health makes leadership appointments in IT, procurement

RICHMOND, Va. – Accendra Health has promoted Nicholas (Nick) Piecora to senior vice president & chief information officer, reporting to Edward Pesicka, president & CEO. It has also promoted Agnes Ansay to vice president & chief procurement officer, reporting to Jonathan Leon, executive vice president & CFO. These appointments, the company says, reflect a deliberate shift to better align strategy and execution as it continues its evolution as a pure play home-based care organization. Accendra Health says Piecora has been a key contributor to the company’s success for nearly 20 years, playing an integral role in the business transformation and is a member of the company leadership team. “Under Nick’s leadership, we will continue to advance our strategy by leveraging technology and automation to deliver industry-leading home-based care, enhance the customer experience, optimize operational and reimbursement performance, and provide a cost-efficient channel-to-market for our manufacturing partners," Pesicka said. Accendra Health says Ansay, a procurement leader with more than 10 years of global experience, will lead the procurement organization, bringing deep expertise in leading high-performing procurement organizations in complex, large-scale environments. Most recently, she served as the head of global procurement for IT, facilities, engineering, and manufacturing at Grifols, transforming a decentralized, tactical procurement function into a centralized global category management organization. She previously held senior procurement and sourcing leadership roles at Amazon, Starbucks, Nordstrom, and Walgreens Boots Alliance. “Agnes is a transformative leader with deep experience building high-performing procurement organizations and driving strategic value creation,” said Leon. “Agnes’ expertise will help us further strengthen our procurement capabilities, a necessary step in driving sustainable growth, improving efficiency, and supporting continued investment in the technologies and innovations necessary to shape our business.”

• Related: Accendra Health lags in Q1, but lays groundwork for standalone status.